Standardization of the preanalytical phase of DNA extraction from fixed tissue for next-generation sequencing analyses.


Journal

New biotechnology
ISSN: 1876-4347
Titre abrégé: N Biotechnol
Pays: Netherlands
ID NLM: 101465345

Informations de publication

Date de publication:
25 Jan 2020
Historique:
received: 05 02 2019
revised: 24 07 2019
accepted: 28 07 2019
pubmed: 10 8 2019
medline: 25 2 2020
entrez: 10 8 2019
Statut: ppublish

Résumé

Next-generation sequencing (NGS) analyses on DNA derived from archived Formalin-Fixed Paraffin-Embedded (FFPE) clinical material can provide a powerful tool in oncology research and clinical diagnostics. Although several studies have established that NGS can be performed using DNA from FFPE tissue, the accuracy and reproducibility of such analyses, as well as their robustness to the biomolecular quality of the samples used, remains a matter of debate. Excellent reviews have recently been published, providing evidence-based best practices for FFPE DNA extraction. Alternative fixatives exist, although their implementation in clinical practice is difficult. In this article, we present (i) a review of fixed tissue DNA preanalytics with a special focus on DNA extraction and fixed tissue sample qualification and (ii) results from comparisons between different methods of DNA extraction from tissue samples that have been fixed or stabilized by different methods, in terms of NGS metrics and different DNA quality metrics.

Identifiants

pubmed: 31398512
pii: S1871-6784(19)30046-9
doi: 10.1016/j.nbt.2019.07.005
pii:
doi:

Substances chimiques

DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-61

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Olga Kofanova (O)

IBBL (Integrated BioBank of Luxembourg), 1 rue Louis Rech, L-3555 Dudelange, Luxembourg. Electronic address: olga.kofanova@ibbl.lu.

Camille Bellora (C)

IBBL (Integrated BioBank of Luxembourg), 1 rue Louis Rech, L-3555 Dudelange, Luxembourg. Electronic address: camille.bellora@ibbl.lu.

Sonia Garcia Frasquilho (S)

IBBL (Integrated BioBank of Luxembourg), 1 rue Louis Rech, L-3555 Dudelange, Luxembourg. Electronic address: sonia.frasquilho@ibbl.lu.

Laurent Antunes (L)

IBBL (Integrated BioBank of Luxembourg), 1 rue Louis Rech, L-3555 Dudelange, Luxembourg. Electronic address: laurent.antunes@lns.etat.lu.

Gael Hamot (G)

IBBL (Integrated BioBank of Luxembourg), 1 rue Louis Rech, L-3555 Dudelange, Luxembourg. Electronic address: gael.hamot@ibbl.lu.

Conny Mathay (C)

IBBL (Integrated BioBank of Luxembourg), 1 rue Louis Rech, L-3555 Dudelange, Luxembourg. Electronic address: conny.mathay@asta.etat.lu.

Kathleen Mommaerts (K)

IBBL (Integrated BioBank of Luxembourg), 1 rue Louis Rech, L-3555 Dudelange, Luxembourg. Electronic address: kathleen.mommaerts@ibbl.lu.

Arnaud Muller (A)

LIH (Luxembourg Institute for Health), 1 A-B Rue Thomas Edison, 1445 Strassen, Luxembourg. Electronic address: arnaud.muller@lih.lu.

Brian DeWitt (B)

IBBL (Integrated BioBank of Luxembourg), 1 rue Louis Rech, L-3555 Dudelange, Luxembourg. Electronic address: brian.dewitt@ibbl.lu.

Fay Betsou (F)

IBBL (Integrated BioBank of Luxembourg), 1 rue Louis Rech, L-3555 Dudelange, Luxembourg. Electronic address: fay.betsou@ibbl.lu.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH